FHTX R&D Expense Growth
Foghorn Therapeutics Inc · R&D Expense Growth
FHTX R&D Expense Growth
Latest reported1.45%period ending
FHTX Quarterly R&D Growth (QoQ) (0.00% → 1.45%)
Latest values, visible window
High-resolution chart · PNG
FHTX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.4459% | |
| -20.4262% | |
| 14.7185% | |
| -4.26% | |
| -3.3941% | |
| 5.4515% | |
| -16.9347% | |
| 3.7484% | |
| -6.8027% | |
| 9.3393% | |
| -11.0396% | |
| -10.2469% | |
| -2.4579% | |
| 6.2996% | |
| 4.7534% | |
| 3.6729% | |
| 5.9817% | |
| 9.1039% | |
| 9.6077% | |
| 9.9346% | |
| -0.4486% | |
| 17.7144% | |
| -1.2723% | |
| 18.2345% | |
| 18.4734% | |
| -14.9186% | |
| 19.7308% | |
| 15.5192% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |